The process of determining the number of plaque-forming units (PFU) per milliliter involves quantifying the concentration of infectious viral particles within a given sample. This calculation relies on performing serial dilutions of a viral stock, infecting susceptible cells with these dilutions, and counting the resulting plaques formed. The final titer is expressed as PFU/mL, representing the number of infectious viral particles capable of forming plaques per milliliter of the original stock. For instance, if a 10-6 dilution results in an average of 50 plaques on a plate inoculated with 0.1 mL of the diluted virus, the calculated titer would be 5 x 108 PFU/mL.
Accurate determination of viral titer is crucial for a variety of applications, including vaccine development, gene therapy, and basic virological research. Knowing the infectious particle concentration allows for consistent and reproducible experimental results. Historically, plaque assays have served as the gold standard for quantifying infectious virus, providing a direct measure of viral infectivity. This quantification process is essential for understanding viral replication kinetics, assessing the efficacy of antiviral compounds, and ensuring the quality control of viral vector production.